12
Total investments
8
Early stage
4
Mid stage
0
Late stage
17y
Years active
Portfolio
12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2023
Qlife is a Danish medical technology company that develops an innovative medical technology platform with the long-term goal of giving people access to safe and validated blood biomarker data at home. The platform called Egoo.health consists of a small diagnostic device with individual capsules containing each a specific biomarker test that can be measured by a single drop of blood from the fingertip.
Board Member
Dec 2021
Gain & Co are independent advisors on robots and automation.
We help companies automate physical processes, optimize existing robot solutions, and provide an expert opinion on how to fix failed projects.
Our advisory and solutions are 100 % independent of robot suppliers to ensure the best result for our customers.
Large enterprises, public organizations, as well as small and medium-sized companies, use our services to get more out of robots and automation through an impartial partner.
They use our services, among other things, for:
- Preparing the organization for automation and robots
- Calculating the potential of automating specific processes.
- Identifying relevant suppliers and solutions.
- Assessing the maturity and viability of different types of solutions
- Handling tenders, including requirement specifications, contracts, vendor negotiations, etc.
We have offices in Denmark, the UK and the US.
Board Member
Dec 2021
#HowToRobot – Connecting the World of Robots.
– A global platform helping companies succeed with automation.
Get access to a worldwide directory of robot suppliers, tools to boost success rate of automating processes in your organization, plus robot insights from the experts.
Investor
Jan 2021
Most websites still work like they did ten years ago.
Visitors search.
Click links.
Dig through pages to find answers.
But expectations have changed. People want direct answers, not navigation.
Raffle turns your website into an AI-powered answer engine.
Instead of forcing visitors to browse pages or search through documents, they can ask questions and receive accurate answers based on your own content.
This improves the experience for visitors and captures the intent behind every question.
Organizations use Raffle to:
Reduce repetitive support questions
Help visitors find information faster
Increase conversion from existing website traffic
Understand what users are actually looking for
Raffle provides AI search and AI chat that work directly on top of your website content, documentation and knowledge base.
The platform is designed to deliver reliable answers grounded in your own data, avoiding hallucinations and ensuring trust.
For organizations with complex information, large content libraries or high support volume, this turns the website into a true decision support layer instead of just a navigation system.
Advisor and Investor
Jan 2019
We build and market off-the-shelf software which use new and patented technology to automate depersonalization of data (PET: Privacy Enhancing Techniques & Privacy by Design).
In that way we enable our customers to use their data faster, more efficient and freely for business purposes, without privacy concerns.
At PII Guard we have invented the next generation of encryption with the strongest algorithm in the world for protection of personally identifiable information (PII). It’s called Type-Preserving Encryption.
Our software solutions are Data Gateway and Analytics Gateway.
By using Data Gateway you can depersonalize data at rest, in transit, in cloud and generate high quality test data.
With Analytics Gateway your website visitors can say goodbye to annoying cookie consent banners, and you can collect +100% more and better data.
+60M end-user identity currently protected by PII Guard, especially within regulated sectors like the Finance, Healthcare, Government & Infrastructure.
We set your data free! – for more business and with stronger protection.
Investor
Jan 2019
Plex has developed a novel AI-driven analytical platform for scientists that puts the underlying scientific data front-and-center -- transparently -- for scientists to see. Plex answers complex drug discovery questions by identifying the convergence of data across far-flung, disparate raw data sources. Plex pieces together clues and hidden connections from massive amounts of data including small molecule bioactivities, gene expression profiles, genomics, proteomics, metabolomics, perturb seq data, clinical trial information, and much more.
Plex works with biotech and pharma companies to address critical questions in drug discovery and development, including target ID/validation, target discovery, disease indication discovery/expansion, biomarker discovery/validation, safety assessment, and precision oncology.
Investor
Jan 2017
Were on a mission to break down the barriers of what swimming is and what it could be. Join a group of innovative thinkers, proactive go-getters, and team players to help us continue to elevate the game-changing swim experience.
Investor
Apr 2016
Strategic capital, in its true form, extends the founding teams capacity. Thats what we do at Rhino. We invest in companies where we can add tangible value.
Investor
Sep 2014
We invest in early stage startups!
At Copenhagen United we want to create more successful startups! We achieve this by investing money (and time) in early stage startups!
Copenhagen United is the brainchild of Nicolaj Højer Nielsen, who wanted to scale up his seed investments by co-investing in startups together with members of his professional network. Copenhagen United is the new vehicle to make this happen.
Rules of engagement:
- No bureaucracy
- No management fees
- No BS
Member of the Board
Nov 2013
Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.
Board Member
Sep 2010
Codesealer stands alone as the industrys only security solution that protects both your source code and conceals APIs by extending encryption beyond TLS into the client.
Unlike any other product, Codesealer effectively removes the attack surface, ensuring only validated sessions and providing unmatched preventative security far beyond traditional threat detection.
Codesealer can be implemented seamlessly – no code changes needed in the application and no agents on the browser.
Dont let your APIs become the next target
Act now to secure your digital assets and stay ahead of evolving cyber threats.
Founding Investor
Feb 2009
Recon Instruments, an Intel company, was founded in 2008 and is the world leader in smart eyewear technology for sports and high-intensity environments. Recon’s award-winning technology is backed by an extensive patent portfolio and integrates high-contrast displays with state-of-the-art computing platforms and sensor suites.
Recon’s smart eyewear technology features an Android-based operating system with an open SDK, empowering developers to create apps for an endless variety of sports and activities. Recon continues to define the smart eyewear category and is dedicated to improving athletic performance and participation in sports.
Experience · 14 entries
All (14)
Investments (12)
Board (5)
2023
Board Member
Apr 2023
Qlife is a Danish medical technology company that develops an innovative medical technology platform with the long-term goal of giving people access to safe and validated blood biomarker data at home. The platform called Egoo.health consists of a small diagnostic device with individual capsules containing each a specific biomarker test that can be measured by a single drop of blood from the fingertip.
General Partner
Jan 2023
Bristlecone Pacific is a venture fund investing in innovative companies developing solutions to extend healthy human lifespan. We believe new interventions, backed by scientific evidence, will enable humans to control the biological aging process and be youthful at any age.
2021
Board Member
Dec 2021
Gain & Co are independent advisors on robots and automation.
We help companies automate physical processes, optimize existing robot solutions, and provide an expert opinion on how to fix failed projects.
Our advisory and solutions are 100 % independent of robot suppliers to ensure the best result for our customers.
Large enterprises, public organizations, as well as small and medium-sized companies, use our services to get more out of robots and automation through an impartial partner.
They use our services, among other things, for:
- Preparing the organization for automation and robots
- Calculating the potential of automating specific processes.
- Identifying relevant suppliers and solutions.
- Assessing the maturity and viability of different types of solutions
- Handling tenders, including requirement specifications, contracts, vendor negotiations, etc.
We have offices in Denmark, the UK and the US.
Board Member
Dec 2021
#HowToRobot – Connecting the World of Robots.
– A global platform helping companies succeed with automation.
Get access to a worldwide directory of robot suppliers, tools to boost success rate of automating processes in your organization, plus robot insights from the experts.
Investor
Jan 2021
Most websites still work like they did ten years ago.
Visitors search.
Click links.
Dig through pages to find answers.
But expectations have changed. People want direct answers, not navigation.
Raffle turns your website into an AI-powered answer engine.
Instead of forcing visitors to browse pages or search through documents, they can ask questions and receive accurate answers based on your own content.
This improves the experience for visitors and captures the intent behind every question.
Organizations use Raffle to:
Reduce repetitive support questions
Help visitors find information faster
Increase conversion from existing website traffic
Understand what users are actually looking for
Raffle provides AI search and AI chat that work directly on top of your website content, documentation and knowledge base.
The platform is designed to deliver reliable answers grounded in your own data, avoiding hallucinations and ensuring trust.
For organizations with complex information, large content libraries or high support volume, this turns the website into a true decision support layer instead of just a navigation system.
Show all 14 entries ↓
Investment activity
2009–2023 · 12 investments
Recent (last 2 years)Earlier
